Medicom and GCI win Reminyl job
Shire Pharmaceuticals has handed 2005 UK PR and medical education work for its Alzheimer’s disease drug Reminyl to Medicom Group, while appointing GCI Healthcare to handle consumer work for the brand.
Sign in to continue
Need to activate your subscription?
Domain/Group Subscriptions
Click here >>
Individual Subscriptions
Click here >>
Need to activate your Subscription
Company Wide Subscriptions
Click here >>
UK Individual Subscribers
Click here >>